Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Ainos, Inc. (NASDAQ:AIMD) has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration for conducting a Phase 2 trial of its drug candidate VELDONA, for treatment of mild symptoms related to COVID-19.
The company has developed its low-dose oral IFN-alpha formulation VELDONA® to boost the human immune response against disease and infection.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
The Phase 2 trial is expected to involve a multicenter and parallel study conducted in Taiwan to evaluate the efficacy of VELDONA in subjects with mild symptoms related to COVID-19.
The enrolled subjects will receive either a daily oral dose of VELDONA or a standard of care (SoC) for 5 days and will be evaluated throughout a 28-day study period.
Chun-Hsien Tsai, Chairman of the Board, President and CEO, commented : "Patients with severe and critical COVID-19 conditions, seem to be affected by an impairment in type I IFN response (no IFN-beta and low IFN-alpha production and activity). Our Company is investigating whether impaired type I IFN could be related to persistent high blood viral loads and inflammatory responses in COVID-19 cases."
The company noted, the previous studies have demonstrated that VELDONA could inhibit respiratory virus infection, including influenza A.
Price Action : Ainos shares are trading around 1 percent down at $2.43 on Wednesday during pre-market session.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.